RxDoctor Payments Data

Brian Kopell, MD

Neurological Surgery · New York, NYNPI 1568413300

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $70,445 of the $98,034 with a category attached, or 71.9%. Abbott accounts for 64.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $30,569 and has fallen 72.0% since, to $8,548 in 2025.

$98,034in general payments, 2019–2025

Across 303 payments — averaging $323.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$63K
  • Turing Medical Technologies$16K
  • Medtronic$16K
  • Clearpoint Neuro, Inc.$2K
  • Boston Scientific$709
  • Insightec,inc$627
  • plus $163 from 1 others
$73,413in research payments, 2019–2025

Across 8 payments — averaging $9176.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$47K
  • Neurocrine Biosciences, Inc.$27K

What the payments were for

  • Consulting fees$70,44572%
  • Speaking & faculty fees$12,24512%
  • Travel & lodging$2,4843%
  • Food & beverage$12,86013%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott144$62,805
Turing Medical Technologies4$15,806
Medtronic(2 entities)129$15,630
Clearpoint Neuro, Inc.5$2,295
Boston Scientific17$709
Insightec,inc3$627
Livanova USA, Inc.1$163

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$98,034 in reported general payments places this provider in the 85th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$197,787
Medicare patients
102
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →